NovaBridge Biosciences (NBP) Other Non-Current Assets (2018 - 2026)

NovaBridge Biosciences (NBP) has reported Other Non-Current Assets for 8 consecutive years, with $2.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non-Current Assets rose 106.01% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (up 106.01% YoY), while the FY2025 annual figure was $2.8 million, up 106.01% from the prior year.
• Other Non-Current Assets improved to $2.8 million in Q4 2025 per NBP's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $4.2 billion in Q4 2021 and bottomed at $464000.0 in Q2 2024.
• Historically, Other Non-Current Assets has averaged $322.4 million across 5 years, with a median of $1.4 million in 2024.
• Annual changes were most pronounced in 2021 — Other Non-Current Assets soared 120462.8% — and 2022, when it tumbled 99.92%.
• NovaBridge Biosciences' Other Non-Current Assets stood at $4.2 billion in 2021, then tumbled by 99.92% to $3.5 million in 2022, then surged by 132.78% to $8.2 million in 2023, then sank by 83.32% to $1.4 million in 2024, then soared by 106.01% to $2.8 million in 2025.
• Business Quant data shows NBP's Other Non-Current Assets at $2.8 million in Q4 2025, $1.1 million in Q3 2025, and $1.2 million in Q2 2025.